title: AML1-ETO positive AML: first report from India.
abstract: Translocation (8;21) is associated with few typical morphological features and favorable prognosis. All patients of AML and MDS with increased blasts (N = 35) according to FAB criteria, presenting (between Jan 2004 to June 2005) to the Department of Hematology, AIIMS were studied. RT-PCR was done for the AML1-ETO fusion transcript in all cases. Overall incidence of AML1-ETO was 28.57% and no correlation was found between AML1-ETO positivity and clinical or hematological parameters except for a direct correlation with absolute blast count (ABC) (a lower ABC in the AML1-ETO positive cases). Interestingly, 1/3 MDS cases were positive for the same fusion transcript and thus, it appears worthwhile to look for AML1-ETO in all cases of MDS with increased blasts. Objective morphological evaluation using a scoring system based on morphological features was not helpful in predicting positivity for AML1-ETO. The effect of this translocation on long-term survival could not be determined by the present study.
authors: Department of Hematology, All India Institute of Medical Sciences, New Delhi.
authors: Pankhi
authors: P
authors: Dutta
authors: Syed K
authors: SK
authors: Hasan
authors: Sudha
authors: S
authors: Sazawal
authors: Bijender
authors: B
authors: Kumar
authors: Jina
authors: J
authors: Bhattacharyya
authors: Monica
authors: M
authors: Jain
authors: Seema
authors: S
authors: Tyagi
authors: Rajat
authors: R
authors: Kumar
authors: H P
authors: HP
authors: Pati
authors: Renu
authors: R
authors: Saxena
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002891:Chromosomes, Human, Pair 21 / Q000235:genetics; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics; D050676:Core Binding Factor Alpha 2 Subunit / Q000235:genetics* / Q000378:metabolism*; D005260:Female; D006801:Humans; D015994:Incidence; D007194:India / Q000453:epidemiology; D015470:Leukemia, Myeloid, Acute / Q000453:epidemiology* / Q000235:genetics / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000453:epidemiology* / Q000235:genetics / Q000503:physiopathology; D015514:Oncogene Proteins, Fusion / Q000235:genetics* / Q000378:metabolism*; D000075142:RUNX1 Translocation Partner 1 Protein; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014178:Translocation, Genetic
chemical_list: C107844:AML1-ETO fusion protein, human; D050676:Core Binding Factor Alpha 2 Subunit; D015514:Oncogene Proteins, Fusion; D000075142:RUNX1 Translocation Partner 1 Protein